Chapter/Section Purchase

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patient Derived Xenograft & PDX Models Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Mice Models
1.2.3 Rat Models
1.3 Market by Application
1.3.1 Global Patient Derived Xenograft & PDX Models Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Pre-clinical Drug Development and Basic Cancer Research
1.3.3 Biomarker Analysis
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Patient Derived Xenograft & PDX Models Market Perspective (2018-2030)
2.2 Patient Derived Xenograft & PDX Models Growth Trends by Region
2.2.1 Patient Derived Xenograft & PDX Models Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Patient Derived Xenograft & PDX Models Historic Market Size by Region (2018-2023)
2.2.3 Patient Derived Xenograft & PDX Models Forecasted Market Size by Region (2023-2030)
2.3 Patient Derived Xenograft & PDX Models Market Dynamics
2.3.1 Patient Derived Xenograft & PDX Models Industry Trends
2.3.2 Patient Derived Xenograft & PDX Models Market Drivers
2.3.3 Patient Derived Xenograft & PDX Models Market Challenges
2.3.4 Patient Derived Xenograft & PDX Models Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patient Derived Xenograft & PDX Models Players by Revenue
3.1.1 Global Top Patient Derived Xenograft & PDX Models Players by Revenue (2018-2023)
3.1.2 Global Patient Derived Xenograft & PDX Models Revenue Market Share by Players (2018-2023)
3.2 Global Patient Derived Xenograft & PDX Models Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Patient Derived Xenograft & PDX Models Revenue
3.4 Global Patient Derived Xenograft & PDX Models Market Concentration Ratio
3.4.1 Global Patient Derived Xenograft & PDX Models Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patient Derived Xenograft & PDX Models Revenue in 2022
3.5 Patient Derived Xenograft & PDX Models Key Players Head office and Area Served
3.6 Key Players Patient Derived Xenograft & PDX Models Product Solution and Service
3.7 Date of Enter into Patient Derived Xenograft & PDX Models Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Patient Derived Xenograft & PDX Models Breakdown Data by Type
4.1 Global Patient Derived Xenograft & PDX Models Historic Market Size by Type (2018-2023)
4.2 Global Patient Derived Xenograft & PDX Models Forecasted Market Size by Type (2023-2030)
5 Patient Derived Xenograft & PDX Models Breakdown Data by Application
5.1 Global Patient Derived Xenograft & PDX Models Historic Market Size by Application (2018-2023)
5.2 Global Patient Derived Xenograft & PDX Models Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Patient Derived Xenograft & PDX Models Market Size (2018-2030)
6.2 North America Patient Derived Xenograft & PDX Models Market Size by Country (2018-2023)
6.3 North America Patient Derived Xenograft & PDX Models Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Patient Derived Xenograft & PDX Models Market Size (2018-2030)
7.2 Europe Patient Derived Xenograft & PDX Models Market Size by Country (2018-2023)
7.3 Europe Patient Derived Xenograft & PDX Models Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Patient Derived Xenograft & PDX Models Market Size (2018-2030)
8.2 Asia-Pacific Patient Derived Xenograft & PDX Models Market Size by Country (2018-2023)
8.3 Asia-Pacific Patient Derived Xenograft & PDX Models Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Patient Derived Xenograft & PDX Models Market Size (2018-2030)
9.2 Latin America Patient Derived Xenograft & PDX Models Market Size by Country (2018-2023)
9.3 Latin America Patient Derived Xenograft & PDX Models Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patient Derived Xenograft & PDX Models Market Size (2018-2030)
10.2 Middle East & Africa Patient Derived Xenograft & PDX Models Market Size by Country (2018-2023)
10.3 Middle East & Africa Patient Derived Xenograft & PDX Models Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Crown Bioscience
11.1.1 Crown Bioscience Company Detail
11.1.2 Crown Bioscience Business Overview
11.1.3 Crown Bioscience Patient Derived Xenograft & PDX Models Introduction
11.1.4 Crown Bioscience Revenue in Patient Derived Xenograft & PDX Models Business (2018-2023)
11.1.5 Crown Bioscience Recent Development
11.2 The Jackson Laboratory
11.2.1 The Jackson Laboratory Company Detail
11.2.2 The Jackson Laboratory Business Overview
11.2.3 The Jackson Laboratory Patient Derived Xenograft & PDX Models Introduction
11.2.4 The Jackson Laboratory Revenue in Patient Derived Xenograft & PDX Models Business (2018-2023)
11.2.5 The Jackson Laboratory Recent Development
11.3 Champions Oncology
11.3.1 Champions Oncology Company Detail
11.3.2 Champions Oncology Business Overview
11.3.3 Champions Oncology Patient Derived Xenograft & PDX Models Introduction
11.3.4 Champions Oncology Revenue in Patient Derived Xenograft & PDX Models Business (2018-2023)
11.3.5 Champions Oncology Recent Development
11.4 Charles River Laboratories
11.4.1 Charles River Laboratories Company Detail
11.4.2 Charles River Laboratories Business Overview
11.4.3 Charles River Laboratories Patient Derived Xenograft & PDX Models Introduction
11.4.4 Charles River Laboratories Revenue in Patient Derived Xenograft & PDX Models Business (2018-2023)
11.4.5 Charles River Laboratories Recent Development
11.5 WuXi Apptec
11.5.1 WuXi Apptec Company Detail
11.5.2 WuXi Apptec Business Overview
11.5.3 WuXi Apptec Patient Derived Xenograft & PDX Models Introduction
11.5.4 WuXi Apptec Revenue in Patient Derived Xenograft & PDX Models Business (2018-2023)
11.5.5 WuXi Apptec Recent Development
11.6 Oncodesign
11.6.1 Oncodesign Company Detail
11.6.2 Oncodesign Business Overview
11.6.3 Oncodesign Patient Derived Xenograft & PDX Models Introduction
11.6.4 Oncodesign Revenue in Patient Derived Xenograft & PDX Models Business (2018-2023)
11.6.5 Oncodesign Recent Development
11.7 Horizon Discovery
11.7.1 Horizon Discovery Company Detail
11.7.2 Horizon Discovery Business Overview
11.7.3 Horizon Discovery Patient Derived Xenograft & PDX Models Introduction
11.7.4 Horizon Discovery Revenue in Patient Derived Xenograft & PDX Models Business (2018-2023)
11.7.5 Horizon Discovery Recent Development
11.8 Pharmatest Services
11.8.1 Pharmatest Services Company Detail
11.8.2 Pharmatest Services Business Overview
11.8.3 Pharmatest Services Patient Derived Xenograft & PDX Models Introduction
11.8.4 Pharmatest Services Revenue in Patient Derived Xenograft & PDX Models Business (2018-2023)
11.8.5 Pharmatest Services Recent Development
11.9 Hera Biolabs
11.9.1 Hera Biolabs Company Detail
11.9.2 Hera Biolabs Business Overview
11.9.3 Hera Biolabs Patient Derived Xenograft & PDX Models Introduction
11.9.4 Hera Biolabs Revenue in Patient Derived Xenograft & PDX Models Business (2018-2023)
11.9.5 Hera Biolabs Recent Development
11.10 EPO Berlin-Buch
11.10.1 EPO Berlin-Buch Company Detail
11.10.2 EPO Berlin-Buch Business Overview
11.10.3 EPO Berlin-Buch Patient Derived Xenograft & PDX Models Introduction
11.10.4 EPO Berlin-Buch Revenue in Patient Derived Xenograft & PDX Models Business (2018-2023)
11.10.5 EPO Berlin-Buch Recent Development
11.11 Xentech
11.11.1 Xentech Company Detail
11.11.2 Xentech Business Overview
11.11.3 Xentech Patient Derived Xenograft & PDX Models Introduction
11.11.4 Xentech Revenue in Patient Derived Xenograft & PDX Models Business (2018-2023)
11.11.5 Xentech Recent Development
11.12 Urolead
11.12.1 Urolead Company Detail
11.12.2 Urolead Business Overview
11.12.3 Urolead Patient Derived Xenograft & PDX Models Introduction
11.12.4 Urolead Revenue in Patient Derived Xenograft & PDX Models Business (2018-2023)
11.12.5 Urolead Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details